CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma is a research paper published in Frontiers in Oncology (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R35 CA220500
NCI NIH HHS
Grant: U54 CA232568
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
American Association for Cancer Research
National Institutes of Health
Alex's Lemonade Stand Foundation for Childhood Cancer
Fields of Study
Keywords
Sustainable Development Goals